Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.000
+0.070 (2.39%)
Dec 20, 2024, 4:00 PM EST - Market closed

Zentalis Pharmaceuticals Revenue

Zentalis Pharmaceuticals had revenue of $40.56M in the twelve months ending September 30, 2024.

Revenue (ttm)
$40.56M
Revenue Growth
n/a
P/S Ratio
5.25
Revenue / Employee
$327,097
Employees
124
Market Cap
213.80M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
biote 193.06M
LifeMD 193.06M
ADC Therapeutics 70.72M
SOPHiA GENETICS 64.49M
Utah Medical Products 44.08M
Precigen 3.96M
Inhibikase Therapeutics 1.00
Revenue Rankings